Patent submission for Optimer® binders in cosmetic products

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has filed a patent application to protect the recently developed Optimer binder sequences for novel applications in fast moving consumer goods generated as part of its partnership with Unilever.

How sham patents are hurting the pharma industry – Pharmaceutical Technology

The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition. Image Credit: Getty Images/boonchai wedmakawand Patent

May 7, 2024

CS MEDICA A/S (von NuWays AG) – Biotech Investments

Original-Research: CS MEDICA A/S – from NuWays AG 04.11.2024 / 09:01 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group

November 5, 2024

HeartMate 3 Safety Concerns; First Cath Lab Standards for Kids; Single-Shot PFA

Thoratec refuted most of the 4,500-plus reports that its HeartMate 3 left ventricular assist device may have caused or contributed to a patient’s death. (CBS

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.